Sugen other research news

SUGN signed an exclusive multi-project CRADA with the NCI under which the company's transcript imaging technology will be used to identify the differences in expression patterns of signal transduction genes that characterize each of the 60 tumor cell lines comprising the NCI's screening panel. Results of the analysis will be correlated with data the NCI has generated over several decades from screenings of thousands of compounds and natural extracts against the panel. ...